Document Classification

Section Type: RESULTS

Text: At 24 weeks, saxagliptin 5 mg + metformin and saxagliptin 10 mg + metformin demonstrated statistically significant adjusted mean decreases vs. saxagliptin 10 mg and metformin monotherapies in HbA1c (-2. 5 and -2. 5 % vs. -1. 7 and -2. 0 %, all p < 0. 0001 vs. monotherapy) and FPG (-60 and -62 mg/dl vs. -31 and -47 mg/dl, both p < 0. 0001 vs. saxagliptin 10 mg ; p = 0. 0002 saxagliptin 5 mg + metformin vs. metformin ; p < 0. 0001 saxagliptin 10 mg + metformin vs. metformin).